Skip to main content
. 2021 Dec 21;2021(12):CD002042. doi: 10.1002/14651858.CD002042.pub5

NCT03309579.

Study name Aneurysmal SubArachnoid Hemorrhage ‐ red blood cell transfusion and outcome (SAHaRA)
Methods RCT (multicentre; international; pragmatic)
Participants Adults with aneurysmal subarachnoid haemorrhage
Estimated enrolment: 740 (including participants enrolled in earlier pilot (NCT02483351))
NCT02483351 is now complete; participants' results will be published when the main trial reports, not separately
Interventions Liberal vs restrictive threshold (10 g/dL vs 8 g/dL)
Outcomes Primary outcome: modified Rankin scale (for measuring functional outcome in stroke)
Mortality will be reported at 12 months
Starting date 2018
Contact information Shane English; senglish@toh.ca
Notes Trial registration (prospective): NCT03309579
Funding: supported by a Transfusion Science research grant awarded by a Canadian Blood Services and Health Canada in partnership with CIHR Institute of Circulatory and Respiratory Health (Canada)